Your briefing

Alys Pharmaceuticals announces CTA submission for ALY-301, the first mast cell selective c-Kit inhibitor for treatment of Cold Urticaria
Meta Is Creating a New A.I. Lab to Pursue ‘Superintelligence’
Israel to deport Gaza activists including Greta Thunberg